The prescription drug Avandia, which helps control diabetes, has been shown to cause serious side effects. Despite these risks, the Food & Drug Administration (FDA) is not issuing a recall; instead, they are restricting the use of Avandia.This comes after a study revealed that there was an increased risk of stroke and heart attack for patients who take Avandia. This is especially true for patients who are already at risk for cardiovascular problems.Meanwhile, the sales for Avandia have been temporarily suspended in Europe. Here in the United States, the restrictions on Avandia will just make it more difficult for doctors to prescribe.There are approximately 600,000 patients in the United States currently taking Avandia. It is believed that these patients can continue to take the prescription diabetes medication if they meet certain requirements.The requirements for continued use of Avandia include:
- there must be no alternative drug that can keep blood sugar under control;
- the drug must currently help to manage blood sugar; and
- doctors must inform patients of its risks.
New prescriptions for Avandia can only be given to patients if they are unable to take Actos, another prescription medication used to treat blood sugar levels. Actos has not been shown to cause the heart problems that are linked to Avandia.If you have been seriously injured by taking Avandia, contact a Chicago product liability lawyer to learn more about filing an Illinois dangerous drug claim. Contact a Chicago Product Liability Lawyer TodayIf you have been seriously injured after experiencing severe Avandia side effects, you may be eligible to file a dangerous drug claim. A Chicago product liability lawyer can evaluate your case, collect the necessary medical evidence and help you file your dangerous drug claim.The Law Offices of Barry G. Doyle, P.C. have tried many cases like yours and understand how liability can spread across one or more defendants. For a no-cost case evaluation and help preparing your evidence, contact us today – 312-263-1080.
